肺高压的临床分类更新

zhouyizmc02

肺高压的临床分类更新   Updated Clinical Classification of Pulmonary Hypertension
2014-03-13 14:40点击：241次发表评论分享到

• 新浪微博
• QQ书签
• 百度文库
• 人人网
• 开心网
• 豆瓣
• QQ空间
  

期刊：《J AM COLL CARDIOL 》2013年12月25期62卷

In 1998, a clinical classification of pulmonary hypertension (PH) was established, categorizing PH into groups which share similar pathological and hemodynamic characteristics and therapeutic approaches. During the 5th World Symposium held in Nice, France, in 2013, the consensus was reached to maintain the general scheme of previous clinical classifications. However, modifications and updates especially for Group 1 patients (pulmonary arterial hypertension [PAH]) were proposed. The main change was to withdraw persistent pulmonary hypertension of the newborn (PPHN) from Group 1 because this entity carries more differences than similarities with other PAH subgroups. In the current classification, PPHN is now designated number 1. Pulmonary hypertension associated with chronic hemolytic anemia has been moved from Group 1 PAH to Group 5, unclear/multifactorial mechanism. In addition, it was decided to add specific items related to pediatric pulmonary hypertension in order to create a comprehensive, common classification for both adults and children. Therefore, congenital or acquired left-heart inflow/outflow obstructive lesions and congenital cardiomyopathies have been added to Group 2, and segmental pulmonary hypertension has been added to Group 5. Last, there were no changes for Groups 2, 3, and 4.
  
主要内容：本文描述了2013年第五届世界肺高压大会对于肺高压临床分类的更新意见。

上一篇：【胸外科手术】低肺功能患者胸腔镜下解剖性肺切除术的围术期结果

下一篇：【获得性心血管病】符合经导管主动脉瓣植入术条件的80岁以上高危患者行微创主动脉瓣置换的疗效

学科代码：心血管病学 呼吸病学　　　关键词：肺高压的临床分类更新